| Use of dynamic contrast-enhanced MRI to measure subtle blood-brain barrier abnormalities. | |
| | |
MedLine Citation:
|
PMID: 21030178 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
There is growing interest in investigating the role of subtle changes in blood-brain barrier (BBB) function in common neurological disorders and the possible use of imaging techniques to assess these abnormalities. Some studies have used dynamic contrast-enhanced MR imaging (DCE-MRI) and these have demonstrated much smaller signal changes than obtained from more traditional applications of the technique, such as in intracranial tumors and multiple sclerosis. In this work, preliminary results are presented from a DCE-MRI study of patients with mild stroke classified according to the extent of visible underlying white matter abnormalities. These data are used to estimate typical signal enhancement profiles in different tissue types and by degrees of white matter abnormality. The effect of scanner noise, drift and different intrinsic tissue properties on signal enhancement data is also investigated and the likely implications for interpreting the enhancement profiles are discussed. No significant differences in average signal enhancement or contrast agent concentration were observed between patients with different degrees of white matter abnormality, although there was a trend towards greater signal enhancement with more abnormal white matter. Furthermore, the results suggest that many of the factors considered introduce uncertainty of a similar magnitude to expected effect sizes, making it unclear whether differences in signal enhancement are truly reflective of an underlying BBB abnormality or due to an unrelated effect. As the ultimate aim is to achieve a reliable quantification of BBB function in subtle disorders, this study highlights the factors which may influence signal enhancement and suggests that further work is required to address the challenging problems of quantifying contrast agent concentration in healthy and diseased living human tissue and of establishing a suitable model to enable quantification of relevant physiological parameters. Meanwhile, it is essential that future studies use an appropriate control group to minimize these influences. |
| | |
Authors:
|
Paul A Armitage; Andrew J Farrall; Trevor K Carpenter; Fergus N Doubal; Joanna M Wardlaw |
Related Documents
:
|
16887188 - Brain development in children and adolescents: insights from anatomical magnetic resona... 3179978 - Computerized tomographic findings and differential diagnostic considerations in subcort... 9575268 - Magnetic resonance of the neonatal brain. 16801648 - Voxel-based detection of white matter abnormalities in mild alzheimer disease. 16200568 - Quantification of cartilage biomechanical and biochemical properties via t1rho magnetic... 17854148 - (18)f-dg pet/ct in detection of recurrence and metastasis of colorectal cancer. |
Publication Detail:
|
Type: Journal Article Date: 2010-10-27 |
Journal Detail:
|
Title: Magnetic resonance imaging Volume: 29 ISSN: 1873-5894 ISO Abbreviation: Magn Reson Imaging Publication Date: 2011 Apr |
Date Detail:
|
Created Date: 2011-03-14 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8214883 Medline TA: Magn Reson Imaging Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 305-14 Citation Subset: IM |
Copyright Information:
|
Copyright © 2010 Elsevier Inc. All rights reserved. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: High-resolution CT for identify patients with smear-positive, active pulmonary tuberculosis.
Next Document: Quantitative assay for bradykinin in rat plasma by liquid chromatography coupled to tandem mass spec...